CRIS Current Research Information System

CAPPELLINI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.435
EU - Europa 2.661
AS - Asia 2.550
AF - Africa 186
SA - Sud America 170
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.402
SG - Singapore 817
CN - Cina 608
VN - Vietnam 593
GB - Regno Unito 572
IT - Italia 548
SE - Svezia 406
DE - Germania 357
HK - Hong Kong 254
IN - India 131
RU - Federazione Russa 123
BR - Brasile 121
FR - Francia 103
IE - Irlanda 95
UA - Ucraina 89
NL - Olanda 85
FI - Finlandia 58
ZA - Sudafrica 53
TG - Togo 52
EE - Estonia 46
CI - Costa d'Avorio 37
BG - Bulgaria 34
CH - Svizzera 34
JO - Giordania 33
JP - Giappone 26
AT - Austria 25
SC - Seychelles 25
BE - Belgio 24
AR - Argentina 23
KR - Corea 21
CA - Canada 18
ID - Indonesia 18
PL - Polonia 14
MX - Messico 13
NG - Nigeria 11
HR - Croazia 10
IR - Iran 9
EC - Ecuador 8
CZ - Repubblica Ceca 6
GR - Grecia 6
CL - Cile 5
ES - Italia 5
PK - Pakistan 5
PY - Paraguay 5
TR - Turchia 5
BD - Bangladesh 4
LT - Lituania 4
PT - Portogallo 4
AU - Australia 3
DZ - Algeria 3
IL - Israele 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CO - Colombia 2
IQ - Iraq 2
KZ - Kazakistan 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
HU - Ungheria 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SV - El Salvador 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.008
Salva come PNG Salva come JPEG
Città #
Singapore 547
Southend 481
Ashburn 361
Chandler 307
Fairfield 271
Hong Kong 253
Santa Clara 226
Houston 197
Ann Arbor 194
Bologna 164
Woodbridge 162
Dong Ket 150
Seattle 149
Wilmington 130
Princeton 110
Beijing 103
Cambridge 96
Dublin 95
Boardman 87
Ho Chi Minh City 86
Hanoi 81
Dallas 63
Hefei 56
New York 54
Lomé 52
Nanjing 51
Padova 51
Westminster 50
Jacksonville 49
Los Angeles 48
Helsinki 47
Abidjan 37
Frankfurt am Main 34
Sofia 34
Amman 33
Berlin 32
Bern 30
Redmond 28
Shenyang 28
Bremen 27
Milan 25
Saint Petersburg 25
Turin 24
Brussels 23
Redondo Beach 23
San Diego 22
Tokyo 22
Munich 21
Changsha 20
Buffalo 19
Florence 19
Jinan 19
Seoul 17
Tianjin 17
Vienna 17
Moscow 16
São Paulo 16
Guangzhou 15
Haiphong 15
Nanchang 15
Falkenstein 14
Hebei 14
Ninh Bình 13
Rome 13
Hangzhou 12
Medford 12
Abeokuta 11
Des Moines 11
Falls Church 11
Jakarta 11
London 11
Redwood City 11
Verona 11
Zhengzhou 11
Da Nang 10
Johannesburg 10
Mülheim 10
Norwalk 10
Chicago 9
Ferrara 9
Nuremberg 9
Parma 9
Amsterdam 8
Biên Hòa 8
Düsseldorf 8
Ningbo 8
Phoenix 8
Shanghai 8
Warsaw 8
Mahé 7
Olalla 7
San Francisco 7
Turku 7
Udine 7
Washington 7
Atlanta 6
Bühl 6
Dearborn 6
Jiaxing 6
Mountain View 6
Totale 5.814
Salva come PNG Salva come JPEG
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 306
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 238
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 233
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 226
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 189
Specific presence of PKC isoforms in low and fast proliferation Moris hepatoma cells 188
Therapeutic targeting of CK2 in acute and chronic leukemias. 186
Effect of PKC inhibition on low and fast proliferating Morris rat hepatoma cell line progression 180
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 180
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 173
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 173
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 172
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 171
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 166
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 165
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 162
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 162
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 161
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine 160
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 158
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts 158
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 154
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES 153
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 153
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 150
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 150
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 149
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 146
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 144
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 144
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 143
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 142
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 142
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 141
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 140
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 140
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells 140
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 139
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 138
Metabolism and signaling activities of nuclear lipids 137
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation 137
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 136
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 136
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 134
Targeting Wnt/beta-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. 133
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 131
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 118
PKC inhibitors induced apoptosis in Morris hepatoma 117
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression 108
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways 108
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. 106
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 104
Improving nelarabine efficacy in refractory/relapsed T-cell Acute Lymphoblastic Leukemia by targeting aberrant PI3K/mTOR signaling 103
SELECTIVE EFFECT OF LENALIDOMIDE ON CELL CYCLE AND INOSITIDE-DEPENDENT ERYTHROID SIGNALLING IN DEL(5Q) CELLS AND MYELODYSPLASTIC SYNDROMES (MDS) 103
null 95
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 81
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 81
Nuclear translocation of PKC-alpha is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 73
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 72
Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood 63
Flow cytometric detection of total and serine 473 phosphorylated Akt 50
Molecular characterization of protein kinase C‐α binding to lamin A 46
HIV-1 Tat Protects CD4+ Jurkat T Lymphoblastoid Cells from Apoptosis Mediated by TNF-Related Apoptosis-Inducing Ligand 44
Intranucleolar localization of DNA topoisomerase IIα is a distinctive feature of necrotic, but not of apoptotic, Jurkat T‐cells 42
Diacylglycerol kinase-θ is localized in the speckle domains of the nucleus 42
The controversial nuclear matrix: a balanced point of view 36
Non-selective beta-blockers enhance resolution of induced infections in animals and healthcare-associated infections in humans 33
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells 33
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-κB activation and cFLIPL up-regulation 32
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27Kip1 and control of cyclin D1 expression 32
Supravital exposure to propidium iodide identifies apoptosis on adherent cells 31
Totale 9.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021616 0 0 0 0 0 45 34 55 62 45 46 329
2021/20221.360 154 17 95 125 108 67 51 87 43 225 218 170
2022/20231.283 112 171 65 179 104 117 58 63 227 17 96 74
2023/2024482 35 52 38 41 32 121 19 46 24 29 22 23
2024/20251.462 42 180 138 78 328 81 89 56 23 106 51 290
2025/20261.865 256 411 308 201 486 203 0 0 0 0 0 0
Totale 9.212